98%
921
2 minutes
20
Asymptomatic dengue virus (DENV) infections have important public health implications but are challenging to identify. We performed a cross-sectional study of reverse transcription quantitative polymerase chain reaction on pooled sera of asymptomatic individuals from the south coast of Kenya at two time periods to identify cases of asymptomatic viremia. Among 2,460 samples tested in pools of 9 or 10, we found only one positive case (0.04% incidence). Although pooling of samples has the potential to be a cost-effective and time-efficient method for asymptomatic DENV detection, mass cross-sectional pooled testing may not provide accurate data on rates of asymptomatic infection, likely owing to a decrease in the sensitivity with pooling of samples, a short period of viremia, or testing in the absence of an outbreak.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10993852 | PMC |
http://dx.doi.org/10.4269/ajtmh.23-0650 | DOI Listing |
Curr Top Microbiol Immunol
August 2025
Laboratory of Immunobiology, Department of Microbiology, Immunology and Parasitology, Universidade Federal de Santa Catarina, Florianópolis, Brasil.
Dengue is the most common arboviral infection in the world, causing up to 400 million cases per year. Although most cases are asymptomatic, the virus can cause a wide range of symptoms varying from high fever and pain, common to several arbovirus infections, to hemorrhagic fever and shock syndrome, which can often be fatal. Despite the association of some genotypes with disease severity, most symptom varieties can be traced to the interaction of the virus with the immune system.
View Article and Find Full Text PDFPLoS One
August 2025
PhD Degree Program in Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.
The mosquito transmitted dengue virus (DENV; family Flaviviridae, genus Orthoflavivirus, species Orthoflavivirus denguei) is a significant public health problem in many tropical and subtropical countries around the world. Human infection by DENV is predominantly asymptomatic in 80% of cases, but the remaining 20% of infections can result in symptoms ranging from a mild undifferentiated fever to life threatening dengue hemorrhagic and dengue shock syndrome. During infection DENV induces changes in the host cell, including changing protein expression, altering the cellular lipids and inducing changes in membrane architecture.
View Article and Find Full Text PDFVaccines (Basel)
July 2025
Johnson & Johnson, 2340 Beerse, Belgium.
Background: The evaluation of antiviral or vaccination strategies for the prevention of dengue infections in a traveler population would require extensive and complex studies. This prospective study aimed to identify a cohort of dengue naïve participants living in Medellín, a dengue endemic area, as a proxy for travelers and to determine the incidence of primary dengue virus (DENV) infection (symptomatic and asymptomatic) in this cohort. In Colombia, epidemic dengue waves occur every 3-4 years, with infected mosquitoes present in ~80% of the territory, including Medellín.
View Article and Find Full Text PDFCurr Res Parasitol Vector Borne Dis
June 2025
Department of Family Medicine and Public Health, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Mosquitoes can carry and spread many diseases caused by bacteria, viruses, or parasites. All these mosquito-borne diseases (MBD) represent a significant global burden of infectious diseases, including morbidity and mortality. This systematic review delves into the multifaceted factors contributing to the spread of MBD in the Middle East and North Africa (MENA) region.
View Article and Find Full Text PDFPLoS Negl Trop Dis
July 2025
Laboratório de Medicina e Saúde Pública de Precisão, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.
Chikungunya disease, caused by the chikungunya virus (CHIKV), is an acute febrile syndrome that frequently leads to chronic musculoskeletal manifestations. Little is known about the incidence, asymptomatic rate, seroconversion and chronicity after acute CHIKV infection in children and adolescents. We leveraged a nested cohort study within a phase III clinical trial of the Dengue vaccine by the Butantan Institute (DEN-03-IB), in Simões Filho (Bahia-Brazil) to characterize the dynamics of CHIKV infection in the pediatric population.
View Article and Find Full Text PDF